IL-1 receptor antagonist (anakinra)

Anakinra is a medication that blocks the effects of a protein called interleukin-1 (IL-1), which is involved in inflammation and immune responses. By preventing IL-1 from binding to its receptors, anakinra reduces inflammation and can help treat conditions where the immune system overreacts, such as rheumatoid arthritis and certain autoinflammatory diseases. It is administered via injection and works by calming excessive immune activity, thereby alleviating symptoms and preventing tissue damage caused by inflammation.